Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Physician Fee Update Methodology Is Target For Congress, HHS In 2002

This article was originally published in The Gray Sheet

Executive Summary

The House Energy & Commerce Committee plans to overhaul Medicare's physician fee schedule annual update formula by the end of the year

You may also be interested in...



CMS Budget Request For 2012 Targets Cost Reductions

As policy-makers continue to grapple with the growth in Medicare and Medicaid spending and its impact on the national debt, President Obama's Feb. 14 budget request for CMS offers targeted funding for activities to help bring some of the programs' costs under better control.

CMS Budget Request For 2012 Targets Cost Reductions

As policy-makers continue to grapple with the growth in Medicare and Medicaid spending and its impact on the national debt, President Obama's Feb. 14 budget request for CMS offers targeted funding for activities to help bring some of the programs' costs under better control.

Device Inpatient Payment, Medicare Contractor Reforms Pass With Drug Bill

The Senate will take up Medicare contractor and inpatient prospective payment reform proposals within the "Medicare Modernization and Prescription Drug Act" of 2002 (HR 4954) after the July 4 recess

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016269

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel